D
Doc and Tell
Pharma & Life Sciences

Document Intelligence for Pharma and Life Sciences Regulatory Affairs

Navigate FDA NDA submissions, clinical study reports, and IND applications with AI that cites every finding to its exact source page — meeting the traceability requirements that regulatory affairs demands.

The Problem

500,000+

pages per NDA submission

in a typical FDA New Drug Application — requiring regulatory affairs teams to cross-reference modules, clinical study reports, and preclinical data across years of research

80%

of RA team time

spent on document review and cross-referencing rather than regulatory strategy — making AI-assisted review a direct multiplier on submission quality

$2.6B

average drug development cost

makes documentation errors and submission delays among the most expensive problems in pharmaceutical development

How Doc and Tell Helps

FDA Submission Analysis

Analyze 510(k) submissions, IND applications, and NDA modules. Ask questions across all CTD sections and receive cited answers tracing to the exact module and page.

Clinical Study Report Review

Extract primary and secondary endpoints, adverse event profiles, statistical results, and protocol deviations from CSRs of any length with page-level citations.

Regulatory Intelligence

Upload regulatory guidance documents, agency letters, and inspection reports. Cross-reference against your submission documents to identify gaps before the agency does.

GxP Audit Trail

Every AI answer includes the source document, module, and page citation — providing the traceability documentation required in GxP-regulated workflows.

Free Tools for Pharma & Life Sciences

Frequently Asked Questions

Can Doc and Tell analyze FDA 510(k) and PMA submissions?
Yes. Upload the submission package and ask questions like "What predicate devices are cited in the substantial equivalence argument?" or "Summarize the clinical performance data." Doc and Tell cites the exact module section for every answer.
How does Doc and Tell handle multi-module CTD submissions?
Upload each CTD module as a separate document into a collection. You can then ask cross-module questions — "What safety data in Module 5 supports the label claims in Module 1?" — and receive answers citing the specific module and page.
Is Doc and Tell suitable for GxP-regulated document workflows?
Doc and Tell provides verifiable, page-level citations for every extracted finding — supporting the traceability requirements of GxP workflows. All documents are encrypted and access-controlled. For 21 CFR Part 11 electronic records requirements, contact our enterprise team.
Can multiple regulatory affairs team members collaborate on submission review?
Yes. Create a shared workspace and invite RA, clinical, and quality team members with appropriate roles. All members can query the same submission documents while access controls prevent exposure of sensitive data across project teams.

Ready to Transform Your Pharma & Life Sciences Workflow?

7-day free Pro trial — no credit card required. Upload your first document in under a minute.